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The transporter associated with antigen processing (TAP) repre-
sents a focal point in the immune recognition of virally or malig-
nantly transformed cells by translocating proteasomal degradation
products into the endoplasmic reticulum–lumen for loading of
MHC class I molecules. Based on a number of experimental data
and the homology to the bacterial ABC exporter Sav1866, we
constructed a 3D structural model of the core TAP complex and
used it to examine the interface between the transmembrane and
nucleotide-binding domains (NBD) by cysteine-scanning and cross-
linking approaches. Herein, we demonstrate the functional impor-
tance of the newly identified X-loop in the NBD in coupling
substrate binding to downstream events in the transport cycle. We
further verified domain swapping in a heterodimeric ABC half-
transporter complex by cysteine cross-linking. Strikingly, either
substrate binding or translocation can be blocked by cross-linking
the X-loop to coupling helix 2 or 1, respectively. These results
resolve the structural arrangement of the transmission interface
and point to different functions of the cytosolic loops and coupling
helices in substrate binding, signaling, and transport.
membrane protein structure  traffic ATPase  substrate recognition 
conformational change  cysteine cross-linking
The transporter associated with antigen processing (TAP) rep-resents a keymachinery inMHC class I antigen presentation by
translocating proteasomal degradation products into the lumen of
the endoplasmic reticulum (ER) for loading onto MHC class I
molecules. Kinetically stable peptide–MHC complexes overcome
the ER quality control and subsequently traffic to the cell surface,
where they are inspected by CD8 cytotoxic T lymphocytes, which
allows for an efficient discrimination of virus-infected or malig-
nantly transformed cells (see refs. 1–3 for review).
TAP belongs to the ABC transporter family, which translocates
a diverse spectrum of solutes across membranes driven by ATP
binding and hydrolysis (4–7). TAP forms a heterodimeric complex
composed of TAP1 and TAP2. Each half-transporter consists of a
transmembrane domain (TMD) and a cytosolic nucleotide-binding
domain (NBD), which binds and hydrolyzes ATP. Based on struc-
tural and biochemical data, the NBDs dimerize in the presence of
ATP in a head-to-tail orientation, inwhich the 2ATPmolecules are
complexed at the dimer interface (8–12). Each ATP-binding site is
characterized by theWalkerAandBmotif completed by theC-loop
of the opposite NBD.
TAP can be structurally and functionally dissected into a core
transport complex composed of 2  6 transmembrane (TM)
helices, which frame the peptide-binding pocket and translocation
pathway, and a unique N-terminal domain (TMD0) per subunit,
which is essential for tapasin binding and the assembly of a
macromolecular MHC class I peptide-loading complex composed
of TAP1, TAP2, tapasin, ERp57, calreticulin, MHC heavy chain,
and 2-microglobin (13–16).
The transport mechanism is composed of an ATP-independent
peptide-binding and an ATP-dependent translocation step (17).
Peptide transport and ATP hydrolysis are tightly coupled, implying
a cross-talk between the TMDs andNBDs (18). A discrete peptide-
binding region has beenmappedwithin the core transport complex;
it comprises the cytosolic loop 2 (CL2), which connects TM4 and
TM5, as well as a stretch of 15 residues following TM6 (19). In
addition, a peptide sensor site has recently been identified in CL1
of TAP1 (CL connecting TM2 and TM3), which transmits a bound
peptide and subsequent translocation events via interdomain com-
munication (20). Peptide binding induces a structural reorganiza-
tion of the TAP complex, most likely via the transmission interface
between the TMDs and NBDs (21).
To date, no high-resolution structure of any eukaryotic ABC
transporter has been solved.However, x-ray structures of 2 bacterial
ABC exporters, Sav1866 from Staphylococcus aureus and MsbA
from Salmonella typhimurium, revealed an enlarged transmission
interface comprising TM helix-extended CLs, which are able to
reach across and contact the X-loop of the NBD of the opposite
subunit by coupling helices (22, 23). However, the functional
importance of this transmission interface and, in particular, its
spatiotemporal organization during the transport cycle is presently
unclear.
To examine the functional relevance of the transmission interface
and domain swapping in a heterodimeric ABC half-transporter
complex, we substituted the conserved glutamate of the newly
identified X-loop of TAP2. By cysteine-scanning mutagenesis of
CL1 and 2 of TAP1, we demonstrated close contacts between the
X-loop and coupling helices 1 and 2 of the opposite half-
transporter. The cross-linked transport complex can be reversibly
arrested in a conformation incompetent in solute binding or
translocation.
Results
Transmission Interface of the TAP Complex. An accurate coordina-
tion of the transport cycle of ABC transporters requires a spatio-
temporal communication between distinct events in the TMDs and
NBDs. For example, the presence of bound solute must be trans-
mitted to the NBDs, which subsequently induce conformational
changes by NBD dimerization, driving solute translocation across
the membrane via conformational changes in the TMDs (18, 20).
To define residues of the transmission interface in TAP, we
constructed a 3D homology model of the core TAP complex based
on the x-ray structure of Sav1866 (22). The final TAP model had
a backbone root-mean-square deviation (RMSD) of 3.08 Å from
the Sav1866 structure. The quality of the TAP1/2 model was
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assessed by using WHATIF on local factors, such as backbone
conformation, bond lengths, side-chain planarity, and overall pack-
ing quality, and was found to be comparable with that of Sav1866.
However, some caveats must be applied when using WHATIF for
analysis of TM proteins (24). Therefore, we performed an addi-
tional analysis of theRamachandran plot by using Swiss-PdbViewer
(25). TheRamachandran plot showed that 99%of all TAP residues
fell within favorable regions, increasing our confidence in the
backbone geometry. The CLs of TAP and Sav1866 are of similar
length and clearly distinct from the short intracellular loops of ABC
importers (Fig. 1A).
The constructed model is in full agreement with a number of
experimental data: (i) the membrane topology (26) and the iden-
tified core transport complex match perfectly the homology model
(13), (ii) the peptide-binding pocket concurs withCL2 (19), and (iii)
the sensor loop in CL1 is optimally positioned adjacent to the
peptide-binding site (20) [see supporting information (SI) Fig. S1].
In the 3D model, the NBDs are close together with distances
reflecting the ATP-bound state and the TMDs opened to the
ER–lumenal site, reflecting an outward-facing conformation. The
CLs are composed of TM extended helices, which are connected by
short coupling helices in parallel orientation to themembrane plane
(Fig. 1A). The X-loop of TAP occupies a central position, in which
the conserved glutamate is surrounded by residues of CL1 and CL2
of the opposite subunit. The X-loop is localized in the -helical
domain of the NBD close to the C-loop, suggesting a role in
transmitting conformational changes generated by ATP binding
and hydrolysis. The sequence conservation of CL1 and CL2 in-
cluding coupling helix 1, the identified peptide sensor and coupling
helix 2, the X-loop as well as the C distances between the CLs, and
the X-loop are shown in Fig. 1B.
Function of the X-loop in Peptide Translocation.Based on the peptide
sensor identified in CL1 next to coupling helix 1 of TAP1 (20) and
the sequence conservation of the X-loop in TAP2 (Fig. 1B), we
focused on the interaction and interdomain communication be-
tween the X-loop of TAP2 and the CLs of TAP1.We first replaced
the conserved glutamate (E602) in Cys-depleted TAP2 with as-
partate, alanine, cysteine, and arginine, respectively. The X-loop
mutants were coexpressed with Cys-less TAP1 at similar levels in
insect cells (Fig. 2A). Importantly, peptide binding to TAP was not
affected, demonstrating that theX-loopmutations did not interfere
with membrane insertion, folding, or heterodimer assembly. Re-
markably, the X-loop mutations showed a reduced transport ac-
tivity, with 50% transport activity for E602C and 20% for E602D
or E602A (Fig. 2B). Complete disruption of peptide transport was
observed for the E602R mutant. Thus, the conserved glutamate in
theX-loopplays an important role in the translocation event but not
in substrate binding.
Functional Differences in CL1 and CL2. To identify residues involved
in interdomain signaling, we applied a cysteine-scanning approach
in CL1 and CL2 of TAP1. Based on the 3D model, we chose
residues that frame the X-loop of TAP2 (Fig. 1). Altogether, 24
single-cysteine TAP1 mutants were coexpressed with
TAP2(E602C) and yielded similar expression levels (Fig. 3A).
Similar to the X-loop, mutations in the CL1, including coupling
helix 1, did not significantly affect peptide binding. The slight
differences correlated with alterations in the expression level.
Remarkably, all mutations in coupling helix 1, except for Q277C,
interfered with the transport activity. In addition, mutations in the
peptide sensor region (G282C, I284C, and R287C) drastically
decreased the transport activity. Strikingly, a different pattern is
observed for mutations in CL2, which comprises the peptide-
binding pocket (19, 27). Only R378C showed a significant decrease
in peptide binding and transport (Fig. 3B). In addition, P375C of
TAP1 strongly influenced peptide transport, whereas peptide bind-
ing was not affected. On average, CL2 is more tolerant to mu-
Fig. 1. The TMD–NBD interface of the TAP complex. (A)
Three-dimensional homology model of the core TAP
complex composed of TAP1 (green) and TAP2 (cyan)
based on the x-ray structure of Sav1866 (PDB ID code
2HYD) (22). Cylinders indicate the TM helices of the extra
N domain. CL1 and CL2 are extensions between TM2 and
TM3 and between TM4 and TM5, respectively. The re-
gion of CL1 and CL2 in TAP1 investigated by cysteine-
scanning and cross-linking is colored orange, and the
X-loop of TAP2 is colored yellow. The conserved gluta-
mate (E602) in the X-loop and residues in CL1 and CL2
(Q277 and A381) are highlighted in red using a stick
representation. A magnification of the transmission in-
terface illustratestheclose interactionofcouplinghelices
1 and 2 with the X-loop of TAP2. TM helices are indicated
by numbers. (B) The multiple alignments of the transmis-
sion interface of different ABC exporters [UniProt acces-
sion numbers: Q03518/9, human TAP1/2 (ABCB2/3);
Q9NP78, human TAPL (ABCB9); P08183, human MDL1
(ABCB1); P63359, S. typhimurium MsbA; and Q99T13, S.
aureus Sav1866] derived by using ClustalW2 is shown.
Coupling helices 1 and 2, the peptide sensor, and the
X-loop are presented. Based on the 3D homology model,
C distances between residues of CL1 and CL2 and E602
(X-loop)arederived.E602 (X-loop),Q277 (CL1),andA381
(CL2) are labeled in red. Residues with significant and
high conservation are bold and shaded dark gray,
respectively.
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tagenesis than CL1 (82% vs 38% of mutations had no effect in
transport). In conclusion, CL1 and CL2 have distinct functions in
peptide binding and transport.
Domain Intertwining in the TAP Complex.We next analyzed contact
sites between the CLs of TAP1 and the X-loop of TAP2 by
oxidative cysteine cross-linking. This approach (28) was very pro-
ductive in exploring the structure and function of E. coli lactose
permease, human cystic fibrosis TM conductance regulator
(CFTR), and P-glycoprotein (P-gp) (29–32). TAP cross-linking
conditions using copper phenanthroline (CuPhe) were established
for the A381/E602C complex (Fig. 4A and Fig. S2). The cysteine of
TAP1 is located in CL2 and influences neither peptide binding nor
transport. Cross-linking was performed on ice to limit thermal
deactivation and structural dynamics of the TAP complex. The
reaction was quenched after 1min. Prolonged reaction time did not
enhance the cross-linking efficiency because of the formation of
sulfhydryl oxoforms (33). Interestingly, double bands at 162/174
kDa and 150/162 kDa were observed for TAP1 and TAP2, respec-
tively. Single-cysteine TAP subunits, expressed alone, yielded a
single band of 174 and 150 kDa for TAP1 and TAP2, respectively,
indicating the formation of homodimeric complexes (34, 35). These
homodimers, which form when one subunit is in excess (35), are
most likely misfolded and thus inactive in peptide binding and
translocation (17, 25). This finding is in line with the observation
that single cysteines placed in eachX-loop can be cross-linked in the
homodimer but not in the heterodimer (data not shown). TAP2
variants with single intrinsic cysteines (C197, C208, and C213) in
combination with Cys-less or A381C TAP1 did not lead to cross-
linked homo- or heterodimers (Fig. S2). Cross-linking is reversible
because only monomeric TAP subunits were observed under
reducing conditions (data not shown). These findings demonstrate
the specificity of the cross-linking between the X-loop (E602C) of
TAP2 and CL1/2 of TAP1.
To examine the distance of the CLs and the X-loop, thereby
verifying the domain intertwining, we performed cysteine-scanning
and cross-linking experiments. Surprisingly, most of the positions in
CL1 of TAP1 led to specific cross-linking with the X-loop of TAP2
with varying efficiency, demonstrating a flexible TMD–NBD in-
terface (Fig. 4B and Fig. S3). Strong cross-linking was observed for
residues of the C-terminal end of coupling helix 1 as well as the
N-terminal half of the peptide sensor. In contrast, in CL2 we
detected strong cross-links with the X-loop only for residues 368,
375, 380, and 381 (Fig. 4C and Fig. S3). This result indicates that
interactions between the X-loop of TAP2 and CL2 of TAP1 are
defined, in contrast to CL1. Similar cross-link patterns were ob-
tained at 4 °C and 37 °C for all mutants (data not shown). The
cross-link pattern did not change significantly at various stages of
the transport cycle (e.g., bound ATP, ADP, peptide or viral
inhibitor ICP47) (Fig. S4). Thus, CL1 appears to be highly dynamic,
given that contacts can still occur between residues over C
distances of up to 20.5 Å (Fig. 1B). In conclusion, these data
demonstrate that the CLs of TAP1 interact with the X-loop of
Fig. 2. Function of the glutamate in the X-loop of TAP2 in the allosteric
coupling between peptide binding and translocation. (A) Peptide binding of
X-loop mutants of TAP2. TAP-containing membranes (35 g of protein) were
incubated with 1 M radio-labeled RRYQKSTEL for 15 min at 4 °C. Unspecific
binding was determined in the presence of an excess of RRYQKSTEL (200M).
The lower portion shows the expression level of X-loop mutants analyzed by
10% SDS/PAGE (20 g of protein per lane) followed by immunoblotting
against TAP1 (mAb 148.3) and TAP2 (mAb 435.3). (B) Peptide transport of
X-loop mutants of TAP2. TAP-containing membranes (150g of protein) were
incubated with fluorescein-labeled peptide [1 M RRYQNSTC(F)L] for 5 min at
32 °C in the presence (black bars) or absence (white bars) of 3 mM ATP. After
lysis, N-core-glycosylated and thus translocated peptides were bound to
ConA-beads and quantified by fluorescence detection after elution with
methyl--D-mannopyranoside. Peptide binding and transport of TAP1(Cys-
less)/TAP2(E602) was normalized to 100%. Data were collected from 3 inde-
pendent experiments. The error bars represent the standard deviation.
Fig. 3. CL1 and CL2 of TAP1 have distinct functions in peptide binding and
translocation. Single-cysteine TAP1 mutants of CL1 (A) or CL2 (B) in complex
with E602C(TAP2) were analyzed for peptide binding (gray bars) and trans-
port (black bars). Peptide binding and transport were performed as described
in the legend of Fig. 2. Specific peptide binding and transport of TAP1(Cys-
less)/TAP2(E602C) was normalized to 100%. Data were collected from 3 inde-
pendent experiments. The error bars represent the standard deviation. Equal
amounts of TAP1 and TAP2 were confirmed by immunoblotting.
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TAP2, providing direct evidence for domain intertwining in het-
erodimeric ABC half-transporters.
Arresting the Transport Cycle by Cross-Linking. ABC exporters,
including TAP, undergo multiple conformational changes during
the transport cycle (5, 20, 21, 23, 36). However, due to the motional
freedom of the CLs investigated herein, differences in cross-linking
could not be resolved during the transport cycle (Fig. S4). There-
fore, we investigated the interdomain communication by arresting
TAP function via cysteine cross-linking. We chose 2 pairs of
mutations, Q277C/E602C and A381C/E602C, containing a single
cysteine in each coupling helix of TAP1. Importantly, these CL
mutations neither affected peptide binding nor transport (see Fig.
3) but instead exhibited high cross-linking efficiency with the
X-loop (Fig. 5). Strikingly, cross-linking of the A381C/E602C
complex impeded both peptide binding and transport, in contrast
to the combination with Cys-less TAP1 (Fig. 5B). Surprisingly,
cross-linking of Q277C/E602C arrested TAP in a translocation-
incompetent state, in which peptide binding was unaffected (Fig.
5C). The transport activity of Cys-less/E602C is only slightly re-
duced due to irreversible oxidation.Most importantly, the transport
activity was fully restored by reduction of the disulfide bond,
indicating that the cross-linking did not lead to an irreversible
misfolding and dead-end pathway. In conclusion, CL2/X-loop
cross-linking inactivates the peptide-binding site, and thus peptide
translocation, whereas CL1/X-loop cross-linking disrupts the inter-
domain communication and prevents the structural rearrange-
ments necessary for completion of the TAP substrate transport
cycle after peptide binding.
Discussion
Peptide binding, transport, and ATP hydrolysis are tightly coordi-
nated in the antigen transport complex TAP, implying an allosteric
communication and signal transduction at the TMD–NBD inter-
face (18, 20). In addition to the Q-loop, the newly identified X-loop
in ABC exporters was proposed to be involved in this cross-talk
(22). By substitution of the conserved glutamate in the X-loop of
TAP2, we first demonstrated that the X-loop is indeed essential for
the coupling of substrate binding to the subsequent translocation
step. We further identified critical residues and contact sites in the
CLs, thereby providing direct evidence for domain intertwining in
a heterodimeric ABC transport complex. Cross-linking of the
X-loop to coupling helix 1 arrests the TAP complex in a translo-
cation-incompetent state, whereas cross-linking to coupling helix 2
inhibits substrate binding and thereby translocation.
The conserved glutamate in the X-loop is important for TAP
function, because peptide transport is strongly impaired by substi-
tution with a positively charged residue. The introduction of a short
hydrophobic side chain or the conservative mutation to aspartate
reduced transport activity to 20%, whereas substitution to cysteine
decreased transport activity by only 50%. The reduced side chain of
aspartate may position the negative charge in a disfavored envi-
ronment. The sulfhydryl group of cysteine is largely tolerated. The
X-loop appears very flexible because it shows a high B-factor in the
x-ray structure of ABC exporters as well as of isolated NBDs (11,
37). We suggest that this region transmits ATP binding and
hydrolysis of the NBDs to the TMDs via structural changes due to
its close proximity to the C-loop, which senses the -phosphate of
the bound ATP in the NBD–NBD interface. Remarkably, the
RSMD of the C atom of the X-loop glutamate in the nucleotide-
free and the ATP-bound state of HlyB-NBD is 3-fold higher than
of the entire NBD (11, 38). However, it should be pointed out that
the glutamate of the X-loop is conserved only in ABC subfamilies
B and C. Whether this region is also part of the transmission
interface in the other subfamilies remains to be addressed in future
studies.
A surprising outcome of this study is that CL1 and CL2 have
different functions. CL1 is important for the allosteric coupling of
substrate binding and the subsequent transport event, whereas CL2
seems to function as an anchor via its coupling helix 2 and is part
of the peptide-binding pocket. The 3D model suggests that the
bulky hydrophobic phenylalanine residues of coupling helix 1 (F275
and F276) point into a hydrophobic core, thus stabilizing CL1, and
substitution of these residues may collapse coupling helix 1. Mu-
tations of hydrophilic and charged residues probably affect the
orientation of CL1 or disrupt interdomain contacts. The function
of CL1 in peptide sensing and allosteric coupling to the ATP-
hydrolysis cycle was proposed recently, with residue 288 of TAP1
found to be in direct contact with the bound peptide; in addition,
it was proposed that this sensor region is structurally reorganized
during the transport cycle (20). Thus, the presence of a bound solute
may be communicated via the adjacent coupling helix 1 to other
parts of the protein responsible for completion of the transport
cycle.
The structure of adenosine 5-[,-imido]triphosphate-bound
andADP-vanadateMsbA [Protein data bank (PDB) IDcodes 3B60
and 3B5Z, respectively] closely correlates to the structure of
Fig. 4. Cysteine cross-linking between the CLs of TAP1 and the X-loop of
TAP2. (A) Oxidative cysteine cross-linking of TAP1(A381C)/TAP2(E602). TAP-
containing membranes (500 g of protein) were incubated in the presence or
absence of 1 mM CuPhe for 1 min at 4 °C. Samples were subjected to nonre-
ducing 6% SDS/PAGE (20g of protein per lane) followed by immunoblotting
against TAP1 and TAP2. The positions of the cross-linked TAP1–TAP2 (high-
lighted in bold), homodimeric (TAP1)2 and (TAP2)2, as well as monomeric TAP1
and TAP2 are indicated. (B and C) The cross-linking of the single-cysteine
mutants of CL1 (B) and CL2 (C) in TAP1 with E602C of TAP2. The conditions are
identical as described above. The efficiency of TAP1–TAP2 cross-linking was
derived from TAP2 immunoblots.
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Sav1866 (PDB ID code 2HYD) (22, 23). Because the Sav1866
crystal structure is at higher resolution, we chose to use only this
structure as a modeling template for an ATP-bound conformation
of TAP. To give an idea of possible TAP conformations, we have
also threaded the sequence of TAP1 and TAP2 onto 3 of the C
MsbA structures: ADP-vanadate trapped (PDB ID code 3B5Z),
closed apo conformation (PDB ID code 3B5X), and open apo
conformation (PDB ID code 3B5W). Comparison of the TAP
models shows that the distance between the C atoms of the CL1
residue 277 and the X-loop residue 602 increases from 7.0 Å in the
ATP-bound state to 26.5 Å in the apo closed state and 63.1 Å in the
apo open state (Table S1). Covalent modification of these residues
by cysteine cross-linking would prevent the structural rearrange-
ments necessary for the transport cycle. These distances from the
Sav1866- andMsbA-basedmodels support the experimental results
that CL1/X-loop cross-linking disrupts interdomain communica-
tion and prevents the structural rearrangements necessary for
completion of the substrate transport cycle, whereas substrate
binding is not affected.
Comparison of the TAP homology models in the apo open and
closed conformation and the ATP-bound conformation showed
that the distance between CL2 and the X-loop did not vary
significantly throughout the transport cycle (Table S1). This model
is supported by the CL2/X-loop cross-linking efficiency, which did
not vary throughout the catalytic cycle. By using peptide photo-
cross-linking and deletion studies, the region comprising CL2 was
previously identified as part of an overlapping peptide-binding
region (19, 27). Here, we could demonstrate that R378 in TAP1 is
essential for peptide binding. The 3D model indicates that this
residue is part of coupling helix 2. Its side-chain points into the
opposite direction of the X-loop and might stay in direct contact
with the peptide. It is tempting to speculate that the positive
guanidinium group forms a salt bridge with theC-terminal carboxyl
group of the peptide, which is essential for recognition. Interest-
ingly, the P375C substitution disrupted the transport function of
TAP, leaving peptide binding unaffected. P375 caps coupling helix
2 by a kink, which may be important for signal transmission.
By oxidative cysteine cross-linking, we verified direct contacts
between the CLs and the X-loop, thus providing evidence for
domain swapping and dynamic transmission interface in the TAP
complex. Based on the number of efficiently cross-linked residues,
CL1 was found to be more flexible than CL2. However, it should
be mentioned that CL1 is in close proximity not only to the X-loop
of the opposite NBD but also to the Q-loop of the NBD in cis as
demonstrated by chemical cross-linking studies using the multidrug
exporter BmrA of B. subtilis (39). On the other hand, CL2 does not
exclusively form contacts with the X-loop but also with the Q-loop
of the trans NBD as shown by chemical cross-linking for P-gp and
CFTR(30, 31, 40).A similar Sav1866-like interdomain organization
was recently found for the yeast ABC exporter Yor1p (41).
The transmission interface, framed by the CLs and the NBDs,
showed considerable flexibility because we detected a similar
cross-linking pattern in the presence of ATP, peptides, ATP plus
AlFx, or the viral inhibitor ICP47 (Fig. S4). A highly dynamic
arrangement of the transmission interface was also recently ob-
served for CFTR (22, 30, 31). The need for conformational changes
in the transmission interface during the transport cycle is supported
by transport inhibition through cross-linking of the CLs with the
NBDs. In BmrA, cross-linking of CL1 with the Q-loop of the NBD
in cis disrupted ATP hydrolysis and substrate transport (39).
Arresting CFTR by chemical cross-linking of CL2 or CL4 with
residues near theQ-loopof the transNBD impaired channel activity
(30, 31). Here, we demonstrate that cross-linking of CL1 with the
X-loop in trans arrested the TAP complex in a transport-
incompetent state, which could, however, still bind peptides. The
transmission interface is not restricted to a narrow region of the
polypeptide chain but rather is distributed among the NBDs and
CLs of the TMDs. Notably, cross-linking of CL2 in TAP1 and the
X-loop in TAP2 impaired not only transport but also peptide
binding. Because CL2 is part of the peptide-binding pocket, it is
likely that the disulfide bridge inactivates the peptide-binding
pocket by structural restrains. Thus, the CLs have different func-
tions in substrate binding, signaling, and translocation.
Materials and Methods
Additional procedures are detailed in SI Materials and Methods.
Homology Modeling of the Core TAP Transport Complex. Each TAP1 and TAP2
half-transporter was modeled on the corresponding subunit of the ADP-boundS.
aureus Sav1866 homodimer (PDB ID code 2HYD) (22). Although the Sav1866
structure was crystallized with ADP, the tight NBD dimer conformation and
outward-facing configuration of the TMDs is believed to represent the ATP-
bound state (22). The Sav1866 conformation allowed us to develop a homology
Fig. 5. Cysteine cross-linking inhibits peptide binding
or translocation. Membranes (500 g of protein) con-
taining variants of TAP1 in combination with
TAP2(E602C) were incubated in the presence or absence
of CuPhe for 1 min at 4 °C. (A) Samples (20g of protein
per lane) were analyzed by nonreducing 6% SDS/PAGE
and immunoblotting. (B) Peptide binding to TAP treated
with (black bars) or without (gray bars) CuPhe. TAP-
containing membranes (35 g of protein) were incu-
bated with radio-labeled RRYQKSTEL (1 M) at 4 °C for
15 min. Unspecific binding was determined in the pres-
ence of an excess of RRYQKSTEL (200M). Peptide bind-
ing to TAP in the absence of CuPhe was normalized to
100%. (C) Peptide transport via TAP treated with (black
bars) or without (gray bars) CuPhe. TAP-containing
membranes (150 g of total protein) were incubated
with fluorescein-labeled RRYQNSTC(F)L (1 M) for 5 min
at32 °C inthepresenceorabsenceof3mMATP.Toshow
reversibility, cross-linked samples were subsequently re-
duced with 100 mM 2-ME for 5 min at 4 °C (dark gray).
ATP-dependent TAP transport activity in the absence of
CuPhe was normalized to 100%. Data were collected
from 3 independent experiments. The error bars repre-
sent the standard deviation.
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model of heterodimeric TAP complex in the ATP-bound state. We aligned the
amino acid sequence of human TAP1 and TAP2 with that of Sav1866 using
ClustalW2 (42). Secondary structure predictions (43) and experimental data on
the membrane topology (26) for the TAP1 and TAP2 TM helices corresponded to
the Sav1866-based alignment. The alignment for core TAP1 (173–741) and TAP2
(141–686), respectively, against Sav1866 revealed 27% and 28% sequence iden-
tity, although this varies markedly between the TMDs and NBDs. The sequence
identity between core TAP1 and Sav1866 is 20% for the TMDs and 37% for the
NBDs. For the alignment between core TAP2 and Sav1866, the sequence identity
is22%fortheTMDsand34%fortheNBDs.Whensequencesimilarity is takeninto
account, these percentages turn to 61% and 56% for the TMDs and to 69% and
63% for the NBDs of TAP1 and TAP2, respectively. TAP1 and TAP2 were modeled
separately by means of MODELLER v9.3 (44). The TAP1 and TAP2 models were
dimerized to reproduce the Sav1866 subunit interface and refined to remove
steric clashes (45). The models were inserted into a 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine lipid bilayer, and the system was solvated (24).
Position restraints on the protein backbone conformation were relaxed over a
40-ps period by using the GROMACS 3.2.1 simulation package to give an energy
minimized TAP1/2 heterodimer.
Cysteine Cross-Linking. TAP-containing membranes (0.5 mg of total protein)
were incubated with CuPhe (1 mM CuSO4/4 mM 1,10-phenanthroline; Sigma) in
100 l of PBS (pH 7.4) for 1 min at 4 °C. The reaction was stopped by addition of
10 mMN-ethylmaleimide (NEM; Sigma). The membranes were washed with 500
l of reaction buffer containing 10 mM EDTA and collected by centrifugation at
20,000  g for 8 min at 4 °C. The membranes were resuspended in SDS-sample
buffer containing 10 mM NEM and were analyzed by nonreducing 6% SDS/PAGE
and immunoblotting with mAbs anti-TAP1 (mAb 148.3) (25) and anti-TAP2 (mAb
435.3) (17). For cleavage of the cross-linked disulfide bonds, 100 mM of DTT was
added to the sample buffer before electrophoresis. To test the effect of cross-
linking on TAP function, the membranes were treated with or without CuPhe for
1 min at 4 °C. Thereafter, the membranes were incubated with or without 100
mM of 2-mercaptoethanol for 5 min at 4 °C and washed twice with 1 ml of PBS
containing 10 mM EDTA. Peptide binding and transport was analyzed as de-
scribed above.
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SI Materials and Methods
Sequence Alignment and Secondary Structure Prediction.The quality
of a homology model is governed directly by the accuracy of the
sequence alignment. In low sequence identity regions such as the
transmembrane domain (TMD), an inaccurate sequence align-
ment potentially alters the residue distribution of the transloca-
tion pore and the interhelical contact points that enable func-
tional regions of TAP1/2 to be identified from the homology
model. Secondary structure predictions were previously per-
formed on TAP1 and TAP2 to pin down the location of
membrane spanning helices (1), improving the quality of the
sequence alignment in this region. The Sav1866 crystal structure
contains 15 helical segments in the TMD alone, arranged into 6
transmembrane helices that extend up to 35 Å into the cyto-
plasm, coupling with the nucleotide-binding domains (NBDs)
(2). To demarcate the membrane embedded regions of each
helix, secondary structure predictions were performed on the
Sav1866 primary sequences using 4 different transmembrane
helix (TM) prediction servers (SOSUI, TMHMM, TopPRED2,
and TMpred) (3–6). To verify the secondary structure predic-
tions, the membrane spanning regions of the Sav1866 were also
identified from a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoeth-
anolamine (POPE) embedded, solvated, and equilibrated
Sav1866 crystal structure (PDB ID code 2HYD). These were
compared to the TAP1 and TAP2 secondary structure predic-
tions and experimentally determined membrane-spanning seg-
ments (1). Although the predictions do not precisely concur with
the experimental predictions, the experimental TAP1/2 and
modeled Sav1866 helix demarcations concur, and the location of
the predicted TMhelices correlated with the secondary structure
alignment, increasing our confidence in the TMD sequence
alignment.
Construction and Expression of Mutants. Single cysteine TAP1
mutants of cytosolic loop 1 (CL1) (T273C, E274C, F275C,
Q278C, and N279C) and of CL2 (I368C, E369C, A370C, P375C,
T376C, V377C, R378C, S379C, F380C, A381C, and N382C)
were generated by ligase chain reaction with the following
primers using Cys-less human TAP1 with a C-terminal His10-tag
as template (1): T273C, CGTCCTGAGACAGGAATGC-
GAATTCTTCCA; E274C, GACAGGAAACCTGCTTCTTC-
CAGCAGAAC; F275C, AACCGAATTCTGCCAGCAGA
ACCAGAC; Q278C, GAATTCTTCCAGTGCAACCAGAC-
CGGCAACAT; N279C, TTCTTCCAGCAGTGCCAGAC-
CGGCAACAT; I368C, CCCAGGTCGCTTGCGAAGCCT
TAAGTG; E369C, CAGGTCGCTATCTGCGCCTTAAGT-
GCTA; A370C, GGTCGCTATC GAATGCTTAAGTGCT-
ATGCC; P375C, GCCTTAAGTGCTATGTGTACCGT-
CAGATC C; T376C, GTGCTATGCCTTGCGTCAGATC-
CTTC; V377C, TGCTATGCCTACCTGC AGATCCT-
TCGCTAA; R378C, TATGCCTACCGTCTGCTCCTTC-
GCTA AC; S379C, CCTACCGTCAGATGCTTCGCTAAC-
GAAGA; F380C, TACCGTCAGATCCTGCGCT AACGAA-
GAAG; A381C, CAGATCCTTCTGTAACGAAGAAG-
GCGAAGCTC; N382C, AGATCCTTCGCTTGCGAA-
GAAGGCGAAGCTC (exchanged nucleotides are underlined).
The single cysteine TAP1 mutants Q277C, G282C, N283C,
I284C, M285C, S286C, R287C, and V288C were generated by
ligase chain reaction as described (7). The single cysteine TAP1
mutants of the CL1 were cloned in the BspTI and MluI sites of
pFastBac1TAP1(Cys-less), whereas the single-cysteine TAP1
mutants of the CL2 were cloned in the SphI and StuI sites of
pFastBac1TAP1(Cys-less). The conserved E602 in the X-loop
of TAP2 was mutated by ligase chain reaction with the following
primers using single-cysteine TAP2(C213) as template: E602C,
TACACCGATGTCGGCTGCAAGGGCTCCCAACTG;
E602R, CCGAT GTCGGCAGAAAGGGCTCCCAACT;
E602D, CCGATGTCGGCGATAAGGGCTCCCA ACT;
E602A, TACACCGATGTCGGCGCTAAGGGCTC-
CCAACT. The X-loop mutants of TAP2 were cloned in the AjiI
and AatII sites of pFasBac1-TAP2(C213). All enzymes for
cloning were purchased from Fermentas. The constructs were
confirmed by DNA sequencing. Baculovirus generation, virus
infection, and protein expression were performed as previously
described (8). Coinfections with baculoviruses containing single-
cysteine TAP1 mutants and single-cysteine TAP2 (X-loop) were
performed with a multiplicity of infection of 5. Infections with
baculovirus containing Cys-less TAP1 in combination with
Cys-depleted TAP2 were performed at a multiplicity of infection
of 3 (1). TAP-containing membranes were prepared as previ-
ously described (7). The protein concentration was determined
by the MicroBCA assay (Pierce).
Peptide Binding Assay. Peptides were radiolabeled with iodine
(125I) (8). TAP-containing membranes (25 g of total protein)
were incubated with 1 M of radio-labeled peptide RRYQKS-
TEL in 50 l of binding buffer (5 mMMgCl2 in PBS, pH 7.4) for
15 min at 4 °C. Unbound peptides were removed by washing the
membranes twice with 100 l of ice-cold binding buffer using a
vacuum manifold with 96-well filter plates (0.65 m of polyvi-
nylidene difluoride membranes, MultiScreen; Millipore). Mem-
brane-associated radioactivity was quantified by -counting.
Background binding was determined in the presence of 200-fold
excess of unlabeled peptide (RRYQKSTEL).
Peptide Transport Assay. TAP-containing membranes (150 g of
total protein) were resuspended in 50 l of binding buffer in the
presence of 3 mM ATP or 2 units of apyrase. The transport
reaction (50 l) was started by adding 1 M of fluorescent
peptide RRYQNSTC(F)L [(F), f luorescein-labeled cysteine] for 5
min at 32 °C and terminated with stop buffer (10 mM EDTA in
PBS, pH 7.4) on ice (9). After centrifugation, the membranes
were solubilized in lysis buffer (50 mM Tris/HCl, 150 mM NaCl,
5 mMKCl, 1 mMCaCl2, 1 mMMnCl2, 1%Nonidet P-40, pH 7.4)
for 20 min on ice. N-core glycosylated, and therefore transported
peptides were recovered overnight at 4 °C with Con A Sepharose
beads (Sigma). After washing with lysis buffer, glycosylated
peptides were eluted with 200 mM methyl--D-mannopyrano-
side (Sigma) in lysis buffer and quantified with a fluorescence
plate reader (ex/em  485/520 nm, Polarstar Galaxy; BMG
Labtech).
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Fig. S1. Sequence alignment, membrane topology, and structural organization of TAP1, TAP2, and Sav1866. ClustalW2 was used for sequence alignment of
human TAP1 (PDB ID code gi:45181465), TAP2 (PDB ID code gi:34638), and Sav1866 (PDB ID code gi:15924856). To verify the secondary structure predictions, the
TM regions of the Sav1866 (orange) were also identified from a POPE embedded, solvated, and equilibrated Sav1866 structure (PDB ID code 2HYD) (2). These
were compared to the TAP1 and TAP2 secondary structure predictions and experimentally determined membrane spanning segments (green and cyan) (1).
Characteristic motifs and loops are indicated. The conserved glutamate residues of the X-loop are illustrated in red. The short (686 aa; PDB ID code gi:34638) and
long TAP2 alleles [703 aa; PDB ID code gi:168985572 (gray)] are shown.
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Fig. S2. Specific cross-linking between the cytosolic loops of TAP1 and the X-loop of TAP2. TAP-containing membranes (500g of total protein) were incubated
in the presence or absence of 1 mM copper phenanthroline (CuPhe) for 1 min at 4 °C. Oxidative cross-linking was terminated by 10 mM each ofN-ethylmaleimide
(NEM) and EDTA. Samples were subjected to nonreducing 6% SDS/PAGE (20 g of protein per lane) followed by immunoblotting against TAP1 and TAP2. The
positions of the cross-linked TAP1–TAP2 (highlighted in bold), homodimeric (TAP1)2 and (TAP2)2 and monomeric TAP1 and TAP2 are indicated.
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Fig. S3. Cysteine cross-linking between CL1 and CL2 of TAP1 and X-loop of TAP2. (A and B) The membranes (500 g of protein) containing different single
cysteine variants of the CL1 (A) and CL2 (B) of TAP1 and TAP2(E602C) were incubated in the presence or absence of 1 mM CuPhe for 1 min at 4 °C. Oxidative
cross-linking was terminated by 10 mM each of NEM and EDTA. Samples were subjected to nonreducing 6% SDS/PAGE (20 g of protein per lane) followed by
immunoblotting against TAP1 and TAP2.
Oancea et al. www.pnas.org/cgi/content/short/0811260106 5 of 8
Fig. S3. continued.
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Fig. S4. Cross-linking efficiency between the X-loop and CL1 or CL2 remains stable at various stages of the transport cycle. TAP-containing membranes (500
g of protein) were incubated with either 10 mM ATP, 10 M R9LQK, 10 M E9D (nonbinder), or 10 M ICP47 for 25 min at 27 °C. For nucleotide trapping,
TAP-containing membranes were preincubated with 1 M RRYQKSTEL (R9LQK) and 5 mM ATP in the presence of 2.5 mM AlFx for 25 min at 27 °C. Afterward,
oxidative cross-linking was initiated in the presence of 1 mM CuPhe for 1 min at 4 °C. Oxidative cross-linking was terminated by 10 mM each of NEM and EDTA.
After metal affinity capture of TAP, cross-linked products were analyzed by nonreducing 6% SDS/PAGE followed by immunoblotting against TAP1 and TAP2.
The positions of the cross-linked heterodimeric TAP1–2 and homodimeric (TAP1)2 are indicated.
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Table S1. CL/X-loop distances in different TAP1/2 models
TAP1/2 model based on
CL1 C distances for
residues 277–602, Å
CL2 C distances for
residues 381–602, Å
Sav1866 (PDB ID code 2HYD) 7.7 20.5
ADP-vanadate MsbA (PDB ID code 3B5Z) 7.0 21.0
closed apo MsbA (PDB ID code 2B5X) 26.5 25.6
open apo MsbA (PDB ID code 2B5W) 63.1 26.0
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